Phenylcyanoguanidines as inhibitors of glucose-induced insulin secretion from beta cells.
3,5-Disubstituted-phenylcyanoguanidines have been identified as activators of SUR1/Kir6.2 potassium channels and as potent inhibitors of insulin release from pancreatic beta cells in vitro.